Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.23048 | 9 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.20436 | 8 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.20938 | 9 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.16044 | 8 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.15266 | 8 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.2849 | 9 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.21925 | 8 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.21394 | 9 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.17834 | 8 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.19496 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.18973 | 8 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.15777 | 8 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.20188 | 9 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.19403 | 8 |